vs
Side-by-side financial comparison of Innventure, Inc. (INV) and PLUS THERAPEUTICS, INC. (PSTV). Click either name above to swap in a different company.
PLUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($1.4M vs $822.0K, roughly 1.7× Innventure, Inc.). PLUS THERAPEUTICS, INC. runs the higher net margin — -417.9% vs -4593.8%, a 4175.9% gap on every dollar of revenue. PLUS THERAPEUTICS, INC. produced more free cash flow last quarter ($-6.3M vs $-82.1M).
Innventure, Inc. is a business development and commercialization firm that partners with large global corporations to turn their underutilized intellectual property and unused R&D innovations into scalable, high-growth independent businesses. It focuses on sectors including sustainability, advanced materials and life sciences, serving primarily North American and European markets.
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecu...
INV vs PSTV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $822.0K | $1.4M |
| Net Profit | $-37.8M | $-5.7M |
| Gross Margin | -1315.8% | — |
| Operating Margin | -3859.1% | -420.0% |
| Net Margin | -4593.8% | -417.9% |
| Revenue YoY | — | -3.2% |
| Net Profit YoY | — | -46.4% |
| EPS (diluted) | $-0.18 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $822.0K | $1.4M | ||
| Q3 25 | $534.0K | $1.4M | ||
| Q2 25 | $476.0K | $1.4M | ||
| Q1 25 | $224.0K | $1.1M | ||
| Q4 24 | — | $1.4M | ||
| Q3 24 | $317.0K | $1.5M | ||
| Q2 24 | — | $1.3M | ||
| Q1 24 | — | $1.7M |
| Q4 25 | $-37.8M | $-5.7M | ||
| Q3 25 | $-28.3M | $-4.4M | ||
| Q2 25 | $-84.2M | $5.2M | ||
| Q1 25 | $-143.0M | $-17.4M | ||
| Q4 24 | — | $-3.9M | ||
| Q3 24 | $-2.2M | $-2.9M | ||
| Q2 24 | — | $-2.9M | ||
| Q1 24 | — | $-3.3M |
| Q4 25 | -1315.8% | — | ||
| Q3 25 | -676.6% | — | ||
| Q2 25 | -501.1% | — | ||
| Q1 25 | 17.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -145.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -3859.1% | -420.0% | ||
| Q3 25 | -5469.1% | -320.8% | ||
| Q2 25 | -29952.5% | -110.6% | ||
| Q1 25 | -116606.3% | -333.9% | ||
| Q4 24 | — | -276.2% | ||
| Q3 24 | -4313.6% | -260.9% | ||
| Q2 24 | — | -289.1% | ||
| Q1 24 | — | -196.7% |
| Q4 25 | -4593.8% | -417.9% | ||
| Q3 25 | -5305.6% | -316.6% | ||
| Q2 25 | -17694.7% | 370.6% | ||
| Q1 25 | -63837.9% | -1643.2% | ||
| Q4 24 | — | -276.4% | ||
| Q3 24 | -697.5% | -197.4% | ||
| Q2 24 | — | -229.9% | ||
| Q1 24 | — | -194.5% |
| Q4 25 | $-0.18 | $0.95 | ||
| Q3 25 | $-0.51 | $-0.04 | ||
| Q2 25 | $-1.60 | $-0.01 | ||
| Q1 25 | $-3.10 | $-1.19 | ||
| Q4 24 | — | $-0.51 | ||
| Q3 24 | $-0.94 | $-0.37 | ||
| Q2 24 | — | $-0.71 | ||
| Q1 24 | — | $-0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.4M | $8.6M |
| Total DebtLower is stronger | $8.3M | — |
| Stockholders' EquityBook value | $204.2M | $4.0M |
| Total Assets | $599.2M | $16.3M |
| Debt / EquityLower = less leverage | 0.04× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.4M | $8.6M | ||
| Q3 25 | $9.1M | $16.6M | ||
| Q2 25 | $7.0M | $6.9M | ||
| Q1 25 | — | $9.9M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | — | $4.8M | ||
| Q2 24 | — | $8.4M | ||
| Q1 24 | — | $3.2M |
| Q4 25 | $8.3M | — | ||
| Q3 25 | $29.5M | — | ||
| Q2 25 | $16.8M | — | ||
| Q1 25 | $12.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $14.9M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $204.2M | $4.0M | ||
| Q3 25 | $190.8M | $5.1M | ||
| Q2 25 | $218.6M | $3.0M | ||
| Q1 25 | $261.5M | $-23.6M | ||
| Q4 24 | — | $-8.9M | ||
| Q3 24 | $-22.3M | $-5.2M | ||
| Q2 24 | — | $-7.6M | ||
| Q1 24 | — | $-4.8M |
| Q4 25 | $599.2M | $16.3M | ||
| Q3 25 | $556.5M | $18.7M | ||
| Q2 25 | $556.0M | $10.3M | ||
| Q1 25 | $660.4M | $12.1M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | $55.7M | $7.0M | ||
| Q2 24 | — | $11.2M | ||
| Q1 24 | — | $5.6M |
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-80.7M | $-6.3M |
| Free Cash FlowOCF − Capex | $-82.1M | $-6.3M |
| FCF MarginFCF / Revenue | -9987.8% | -459.9% |
| Capex IntensityCapex / Revenue | 172.4% | 2.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-139.8M | $-20.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-80.7M | $-6.3M | ||
| Q3 25 | $-19.6M | $-2.5M | ||
| Q2 25 | $-22.1M | $-5.8M | ||
| Q1 25 | $-14.7M | $-6.2M | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | — | $-3.7M | ||
| Q2 24 | — | $-1.1M | ||
| Q1 24 | — | $-4.5M |
| Q4 25 | $-82.1M | $-6.3M | ||
| Q3 25 | $-20.0M | $-2.6M | ||
| Q2 25 | $-22.1M | $-5.8M | ||
| Q1 25 | $-15.6M | $-6.2M | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | — | $-3.7M | ||
| Q2 24 | — | $-1.2M | ||
| Q1 24 | — | $-4.6M |
| Q4 25 | -9987.8% | -459.9% | ||
| Q3 25 | -3747.8% | -184.3% | ||
| Q2 25 | -4637.2% | -417.6% | ||
| Q1 25 | -6970.1% | -583.1% | ||
| Q4 24 | — | -86.5% | ||
| Q3 24 | — | -253.7% | ||
| Q2 24 | — | -96.2% | ||
| Q1 24 | — | -271.5% |
| Q4 25 | 172.4% | 2.2% | ||
| Q3 25 | 82.2% | 1.9% | ||
| Q2 25 | 3.2% | 0.5% | ||
| Q1 25 | 409.4% | 0.3% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 6.3% | ||
| Q1 24 | — | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.13× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
